Get the Stockscreener App
29.73
0.13%
0.04
After Hours:
29.73
Enovis Corp stock is traded at $29.73, with a volume of 506.31K.
It is up +0.13% in the last 24 hours and down -6.27% over the past month.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
See More
Previous Close:
$29.69
Open:
$30.33
24h Volume:
506.31K
Relative Volume:
0.46
Market Cap:
$1.70B
Revenue:
$2.19B
Net Income/Loss:
$-829.17M
P/E Ratio:
-2.0863
EPS:
-14.25
Net Cash Flow:
$-3.95M
1W Performance:
-4.89%
1M Performance:
-6.27%
6M Performance:
-7.12%
1Y Performance:
-26.08%
1-Day Range:
$29.71
$30.48
1-Week Range:
$29.51
$32.11
52-Week Range:
$25.46
$49.83
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
29.73 | 1.70B | 2.19B | -829.17M | -3.95M | -14.25 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
Is Enovis Corporation stock a defensive play in 2025Trade Exit Report & Fast Exit Strategy with Risk Control - newser.com
Is Enovis Corporation (C520) stock bottoming after sell off2025 Volume Leaders & Fast Gain Swing Trade Alerts - newser.com
How Enovis Corporation stock compares to growth peersJobs Report & Accurate Technical Buy Alerts - newser.com
Enovis Sells Dr. Comfort Business to Promus Equity Partners for Up to $60 Million - MyChesCo
What to expect from Enovis Corporation in the next 30 days2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com
Key resistance and support levels for Enovis CorporationJuly 2025 Retail & Verified Momentum Watchlists - newser.com
How hedge fund analytics apply to Enovis Corporation stock2025 Major Catalysts & Breakout Confirmation Trade Signals - newser.com
Lawson Kroeker Investment Management Inc. NE Buys 13,566 Shares of Enovis Corporation $ENOV - MarketBeat
A Fresh Look at Enovis (ENOV) Valuation After Dr. Comfort Segment Sale and Strategic Refocus - Yahoo Finance
Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know - Yahoo
What downside risks could hit Enovis Corporation (C520) stockEarnings Miss & High Conviction Investment Ideas - newser.com
Applying Elliott Wave Theory to Enovis CorporationJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
Enovis (NYSE:ENOV) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Enovis (ENOV) Stock Trades Up, Here Is Why - Yahoo Finance
Enovis Sells Dr. Comfort Footcare Solutions Business To Promus Equity Partner For $60M - citybiz
Enovis (ENOV) Divests Dr. Comfort Shoe Business for Up to $60 Mi - GuruFocus
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million - The Manila Times
Enovis Corporation Sells Dr. Comfort Diabetic Shoe Business to Promus Equity Partners for Up to $60 Million - Quiver Quantitative
Up to $60M proceeds — Enovis completes sale of Dr. Comfort to Promus Equity Partners Oct. 8, 2025 - Stock Titan
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $44 - 富途牛牛
What analysts say about Enovis Corporation C520 stockStock Price Divergence & Low Risk Wealth Building - earlytimes.in
DAVENPORT & Co LLC Sells 228,850 Shares of Enovis Corporation $ENOV - MarketBeat
Can Enovis Corporation rally from current levelsQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
Can Enovis Corporation (C520) stock sustain breakout momentumWeekly Market Summary & Safe Entry Zone Identification - newser.com
Long term hold vs stop loss in Enovis Corporation2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Enovis (ENOV): Exploring the Stock’s Undervalued Status After Recent 5% Upswing - simplywall.st
Shareholders in Enovis (NYSE:ENOV) Have Lost 17%, as Stock Drops 14% This Past Week - 富途牛牛
Lecap Asset Management Ltd. Buys New Stake in Enovis Corporation $ENOV - MarketBeat
Public Employees Retirement System of Ohio Decreases Stock Position in Enovis Corporation $ENOV - MarketBeat
Volatility clustering patterns for Enovis CorporationPortfolio Return Report & AI Powered Market Entry Ideas - newser.com
Smart tools for monitoring Enovis Corporation’s price action2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
What is the fair value of Enovis Corporation stock nowDollar Strength & Real-Time Volume Surge Alerts - newser.com
Enovis CEO Matt Trerotola Announces Retirement, Leadership Transition Underway - MSN
Is Enovis Corporation C520 a good long term investmentResistance Breakout Alerts & Minimal Capital Growth - Early Times
Enovis (NYSE:ENOV) Shareholders Have Endured a 21% Loss From Investing in the Stock Three Years Ago - 富途牛牛
Enovis Corporation (NYSE:ENOV) Receives Average Rating of "Buy" from Analysts - MarketBeat
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Enovis Corp Stock (ENOV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Tandy Bradley J | SVP and Chief Legal Officer |
Aug 22 '25 |
Buy |
31.41 |
3,200 |
100,512 |
43,515 |
| BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer |
Aug 20 '25 |
Buy |
29.71 |
2,500 |
74,275 |
116,729 |
| PRYOR DANIEL A | EVP, Strategy & Business Dev. |
Aug 13 '25 |
Buy |
28.90 |
10,000 |
289,000 |
161,115 |
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):